PA
FDMT icon

Parallel Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Parallel Advisors’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Hold
17,887
– – ﹤0.01% 1276
2025
Q4 		$134K Sell
17,887
-1,858
-9% -$18.8K ﹤0.01% 1301
2025
Q3 		$172K Hold
19,745
– – ﹤0.01% 1126
2025
Q2 		$73.3K Hold
19,745
– – ﹤0.01% 1520
2025
Q1 		$63.8K Hold
19,745
– – ﹤0.01% 1500
2024
Q4 		$110K Sell
19,745
-33
-0.2% -$259 ﹤0.01% 1218
2024
Q3 		$214K Hold
19,778
– – 0.01% 894
2024
Q2 		$415K Buy
19,778
+19,745
+59,833% +$495K 0.01% 591
2024
Q1 		$1.05K Hold
33
– – ﹤0.01% 2925
2023
Q4 		$669 Buy
+33
New +$434 ﹤0.01% 3014
2023
Q3 		– Hold
0
– – – 3410

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return